PDLI Latest Press Releases, PDL BioPharma Corporate News

Open account

Releases

2.470

0.00%

0.00

All
Financials
Insiders

10-K PDL BIOPHARMA, INC. (0000882104) (Filer)
Mar 26,2021 18:32
SC TO-I/A PDL BIOPHARMA, INC. (0000882104) (Subject)
Feb 19,2021 17:13
SC 13G/A PDL BIOPHARMA, INC. (0000882104) (Subject)
Feb 12,2021 15:20
SC 13G/A PDL BIOPHARMA, INC. (0000882104) (Subject)
Feb 11,2021 16:22
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 04,2021 00:15
4 PDL BIOPHARMA, INC. (0000882104) (Issuer)
Feb 03,2021 17:57
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:20
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:20
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:19
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:18
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:17
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:16
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 16:16
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 00:15
EFFECT PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 02,2021 00:15
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 01,2021 16:04
POS AM PDL BIOPHARMA, INC. (0000882104) (Filer)
Feb 01,2021 16:03
SC TO-I PDL BIOPHARMA, INC. (0000882104) (Subject)
Jan 15,2021 17:23
SC 13D PDL BIOPHARMA, INC. (0000882104) (Subject)
Jan 11,2021 17:27
4 PDL BIOPHARMA, INC.
Dec 23,2020 17:50
4 PDL BIOPHARMA, INC.
Dec 22,2020 19:51
4 PDL BIOPHARMA, INC.
Dec 17,2020 16:49
4 PDL BIOPHARMA, INC.
Dec 17,2020 16:48
4 PDL BIOPHARMA, INC.
Dec 17,2020 16:48
SC 13G PDL BIOPHARMA, INC.
Dec 15,2020 18:59
8-K PDL BIOPHARMA, INC. (0000882104) (Filer)
Dec 14,2020 08:36
4 PDL BIOPHARMA, INC. (0000882104) (Issuer)
Dec 04,2020 21:17
4 PDL BIOPHARMA, INC. (0000882104) (Issuer)
Dec 04,2020 21:17
Form4 PDL BIOPHARMA, INC.
Nov 20,2020 20:22
Form4 PDL BIOPHARMA, INC.
Nov 20,2020 20:22
Form4 PDL BIOPHARMA, INC.
Nov 20,2020 20:22
Form4 PDL BIOPHARMA, INC.
Nov 19,2020 17:33
Form10-Q PDL BIOPHARMA, INC.
Nov 12,2020 20:51
Form8-K PDL BIOPHARMA, INC.
Nov 12,2020 20:45
Form8-K PDL BIOPHARMA, INC.
Oct 07,2020 16:01
FormSC TO-I/A PDL BIOPHARMA, INC.
Oct 05,2020 16:33
Form8-K PDL BIOPHARMA, INC.
Oct 02,2020 08:35
Form4 PDL BIOPHARMA, INC.
Oct 01,2020 17:52
Form3 PDL BIOPHARMA, INC.
Sep 17,2020 18:13
FormSC TO-I/A PDL BIOPHARMA, INC.
Sep 15,2020 16:02
Form8-K PDL BIOPHARMA, INC.
Sep 10,2020 16:01
Form8-K PDL BIOPHARMA, INC.
Sep 10,2020 08:32
8-K PDL BIOPHARMA, INC. (0000882104) (Filer)
Sep 09,2020 08:32
Form8-K PDL BIOPHARMA, INC.
Aug 31,2020 21:38

Webull provides the latest PDL BioPharma (PDLI) stock and general news. This information may help you make smarter investment decisions.

About PDLI

PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or soon-to-be approved. The counterparties in these transactions can be biotechs, pharmas, medtech companies, universities and inventors.